U.S. Army orthopedic surgeons recently presented studies at the American Academy of Orthopaedic Surgeons focusing on sports medicine-related topics, according to a news release.
The studies presented include:
• "History of Shoulder Instability and Subsequent Injury During Four Years of Follow-Up: A Survival Analysis" which studied 714 patients and concluded those with a prior history of instability were five times more likely to sustain acute instability than those without.
• "Outcomes After Bankart Repair in Military Population: Predictors for Surgery Revision and Long-Term Disability," which studied 3,230 patients who underwent arthroscopic repair and 624 patients who had open repairs. During the seven-year study period, 193 patients had an additional stabilization procedure while 237 were discharged with complaints of shoulder instability and 100 patients underwent revision procedures. The total combined failure rate was 8.6 percent.
Related Articles on Orthopedic Surgery:
Dr. James Andrews Performs Shoulder Surgery on Pitcher Rich Harden
Dr. Victor Hsu Uses Newly FDA-Approved PASS MIS System
Orthopedic Defensive Medicine Costs Estimated at $2B Annually
• "History of Shoulder Instability and Subsequent Injury During Four Years of Follow-Up: A Survival Analysis" which studied 714 patients and concluded those with a prior history of instability were five times more likely to sustain acute instability than those without.
• "Outcomes After Bankart Repair in Military Population: Predictors for Surgery Revision and Long-Term Disability," which studied 3,230 patients who underwent arthroscopic repair and 624 patients who had open repairs. During the seven-year study period, 193 patients had an additional stabilization procedure while 237 were discharged with complaints of shoulder instability and 100 patients underwent revision procedures. The total combined failure rate was 8.6 percent.
Related Articles on Orthopedic Surgery:
Dr. James Andrews Performs Shoulder Surgery on Pitcher Rich Harden
Dr. Victor Hsu Uses Newly FDA-Approved PASS MIS System
Orthopedic Defensive Medicine Costs Estimated at $2B Annually